Advertisement
Loading...

Idorsia Ltd

IDRSFPNK
Healthcare
Biotechnology
$5.75
$0.00(0.00%)
U.S. Market is Open • 15:39

Idorsia Ltd Fundamental Analysis

Idorsia Ltd (IDRSF) shows moderate financial fundamentals with a PE ratio of -5.18, profit margin of -1.01%, and ROE of 19.27%. The company generates $0.2B in annual revenue with strong year-over-year growth of 96.43%.

Key Strengths

PEG Ratio0.05
Current Ratio1.60

Areas of Concern

Operating Margin-57.27%
We analyze IDRSF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 2.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
2.0/100

We analyze IDRSF's fundamental strength across five key dimensions:

Efficiency Score

Weak

IDRSF struggles to generate sufficient returns from assets.

ROA > 10%
-46.02%

Valuation Score

Excellent

IDRSF trades at attractive valuation levels.

PE < 25
-5.18
PEG Ratio < 2
0.05

Growth Score

Excellent

IDRSF delivers strong and consistent growth momentum.

Revenue Growth > 5%
96.43%
EPS Growth > 10%
64.14%

Financial Health Score

Excellent

IDRSF maintains a strong and stable balance sheet.

Debt/Equity < 1
-1.12
Current Ratio > 1
1.60

Profitability Score

Weak

IDRSF struggles to sustain strong margins.

ROE > 15%
19.27%
Net Margin ≥ 15%
-1.01%
Positive Free Cash Flow
No

Key Financial Metrics

Is IDRSF Expensive or Cheap?

P/E Ratio

IDRSF trades at -5.18 times earnings. This suggests potential undervaluation.

-5.18

PEG Ratio

When adjusting for growth, IDRSF's PEG of 0.05 indicates potential undervaluation.

0.05

Price to Book

The market values Idorsia Ltd at -0.97 times its book value. This may indicate undervaluation.

-0.97

EV/EBITDA

Enterprise value stands at 0.58 times EBITDA. This is generally considered low.

0.58

How Well Does IDRSF Make Money?

Net Profit Margin

For every $100 in sales, Idorsia Ltd keeps $-1.01 as profit after all expenses.

-1.01%

Operating Margin

Core operations generate -57.27 in profit for every $100 in revenue, before interest and taxes.

-57.27%

ROE

Management delivers $19.27 in profit for every $100 of shareholder equity.

19.27%

ROA

Idorsia Ltd generates $-46.02 in profit for every $100 in assets, demonstrating efficient asset deployment.

-46.02%

Following the Money - Real Cash Generation

Operating Cash Flow

Idorsia Ltd generates limited operating cash flow of $-125.36M, signaling weaker underlying cash strength.

$-125.36M

Free Cash Flow

Idorsia Ltd generates weak or negative free cash flow of $-139.68M, restricting financial flexibility.

$-139.68M

FCF Per Share

Each share generates $-0.56 in free cash annually.

$-0.56

FCF Yield

IDRSF converts -12.30% of its market value into free cash.

-12.30%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5.18

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.05

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.97

vs 25 benchmark

P/S Ratio

Price to sales ratio

5.21

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.12

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.60

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.19

vs 25 benchmark

ROA

Return on assets percentage

-0.46

vs 25 benchmark

ROCE

Return on capital employed

-0.38

vs 25 benchmark

How IDRSF Stacks Against Its Sector Peers

MetricIDRSF ValueSector AveragePerformance
P/E Ratio-5.1828.65 Better (Cheaper)
ROE19.27%795.00% Weak
Net Margin-100.92%-49787.00% (disorted) Weak
Debt/Equity-1.120.40 Strong (Low Leverage)
Current Ratio1.603.73 Neutral
ROA-46.02%-20255.00% (disorted) Weak

IDRSF outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Idorsia Ltd's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

104.85%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

83.26%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

72.05%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ